Target intelligence / Profile preview

Influenza A virus hemagglutinin H3 (HA (H3))

Target
HA (H3)
Molecular classification
Glycoprotein, Viral fusion protein, Class I fusion protein
01

Overview

Influenza A virus hemagglutinin H3 is a homotrimeric glycoprotein on the virus surface, consisting of HA1 and HA2 subunits linked by disulfide bonds, with a globular head domain for sialic acid receptor binding and a stem domain for membrane anchoring and pH-triggered fusion of viral and host endosomal membranes during entry.[2][3][4][5] The head (HA1) enables attachment to sialic acid on host cells like respiratory epithelium, while the stem (HA2) drives fusion at low pH (5.0-6.0), releasing viral genome.[2][3][4] H3 is one of 16 HA subtypes, key in H3N2 strains causing seasonal influenza and pandemics like 1968 Hong Kong flu; it evolves via mutations and N-glycosylation to evade immunity.[1][2][3] The receptor binding site shows variations for α2,6-linked sialic acid preference in human strains.[3] HA is the primary antigen, targeted by neutralizing antibodies, with conserved stem epitopes for broad protection efforts.[1][3][6]

Other names
H3 hemagglutininH3 HAInfluenza hemagglutinin subtype H3
02

Biological functions

Receptor bindingMembrane fusionViral attachmentViral entry
03

Disease associations

Infection
04

Safety considerations

Antigenic driftAntigenic shiftGlycan shielding of epitopes

Beyond the preview

Go deeper on Influenza A virus hemagglutinin H3 (HA (H3)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus hemagglutinin H3 (HA (H3)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call